Word

SAREPTA

Status

Registered

Status Code

700

Status Date

Tuesday, May 4, 2021

Serial Number

88514961

Registration Number

6342349

Registration Date

Tuesday, May 4, 2021

Mark Type

4000

Filing Date

Monday, July 15, 2019

Published for Opposition

Tuesday, February 25, 2020

Trademark Owner History

Sarepta Therapeutics, Inc. - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Trademark Events

May 4, 2021

Registered-Principal Register

Apr 2, 2021

Notice Of Acceptance Of Statement Of Use E-Mailed

Apr 1, 2021

Allowed Principal Register - Sou Accepted

Mar 19, 2021

Statement Of Use Processing Complete

Mar 1, 2021

Use Amendment Filed

Mar 19, 2021

Case Assigned To Intent To Use Paralegal

Mar 1, 2021

Teas Statement Of Use Received

Oct 22, 2020

Notice Of Approval Of Extension Request E-Mailed

Oct 20, 2020

Extension 1 Granted

Oct 20, 2020

Extension 1 Filed

Oct 20, 2020

Teas Extension Received

Apr 21, 2020

Noa E-Mailed - Sou Required From Applicant

Feb 25, 2020

Official Gazette Publication Confirmation E-Mailed

Feb 25, 2020

Published For Opposition

Feb 5, 2020

Notification Of Notice Of Publication E-Mailed

Jan 17, 2020

Assigned To Lie

Jan 14, 2020

Approved For Pub - Principal Register

Jan 13, 2020

Teas/Email Correspondence Entered

Jan 13, 2020

Correspondence Received In Law Office

Jan 13, 2020

Teas Response To Office Action Received

Oct 3, 2019

Notification Of Non-Final Action E-Mailed

Oct 3, 2019

Non-Final Action E-Mailed

Oct 3, 2019

Non-Final Action Written

Sep 30, 2019

Assigned To Examiner

Jul 19, 2019

New Application Office Supplied Data Entered In Tram

Jul 18, 2019

Teas Amendment Entered Before Attorney Assigned

Jul 18, 2019

Teas Voluntary Amendment Received

Jul 18, 2019

New Application Entered In Tram